Blog LevitasBio Secures $18 Million in Series B Funding Led by Thalys Medical Read More January 5, 2021
Viable Cell Enrichment Technical Challenges of Conventional Cell-Sorting Methods Read More March 1, 2020
Blog Interrogating Cancer Drivers via CRISPR: Mutant TP53 as a Therapeutic Target in Hypodiploid B-cell Acute Lymphoblastic Leukemia Read More January 1, 2018